Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin plus routine therapy in advanced breast cancer
NCT03405168Phase 2Completed
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2018
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of moxifloxacin in breast cancer, sponsored by Sun Yat-sen University. Started Jan 2018; status: completed.
02
Drugs
moxifloxacin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03405168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03405168.